Potassium phosphate and Pleural effusion - a phase IV clinical study of FDA data

Summary:

Pleural effusion is reported as a side effect among people who take Potassium phosphate (potassium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Hypophosphataemia.

The phase IV clinical study analyzes which people have Pleural effusion when taking Potassium phosphate. It is created by eHealthMe based on reports of 571 people who have side effects when taking Potassium phosphate from the FDA, and is updated regularly.

What is Potassium phosphate?

Potassium phosphate has active ingredients of potassium. eHealthMe is studying from 578 Potassium phosphate users. Check the latest studies of Potassium phosphate.

What is Pleural effusion?

Pleural effusion (water on the lungs) is found to be associated with 2,224 drugs and 3,144 conditions by eHealthMe. Check the latest studies of Pleural effusion.

On Jul, 06, 2026

571 people reported to have side effects when taking Potassium phosphate.
Among them, 19 people (3.33%) have Pleural effusion.

Could Potassium phosphate cause Pleural effusion?

Among these 19 people:

How long have people been on Potassium phosphate when they have Pleural effusion? *

What is the gender of people who have Pleural effusion when taking Potassium phosphate? *

female: 42.11 %
male: 57.89 %

What is the age of people who have Pleural effusion when taking Potassium phosphate? *

What are other drugs people take besides Potassium phosphate? *

What are other side effects people have besides Pleural effusion? *

Febrile Neutropenia (fever with reduced white blood cells): 8 people, 42.11%
Fever: 7 people, 36.84%
Dyspnea (difficult or laboured breathing): 6 people, 31.58%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 5 people, 26.32%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 4 people, 21.05%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 4 people, 21.05%
Septic Shock (shock due to blood infection): 4 people, 21.05%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 4 people, 21.05%
Constipation: 4 people, 21.05%
Hyperkeratosis (thickening of the outer layer of the skin): 4 people, 21.05%

What are the existing conditions these people have? *

Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 12 people, 63.16%
High Blood Pressure: 10 people, 52.63%
Hypokalemia (low potassium): 7 people, 36.84%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 26.32%
Constipation: 4 people, 21.05%
Depression: 4 people, 21.05%
Indigestion: 4 people, 21.05%
Diabetes: 4 people, 21.05%
Bladder Disorder: 4 people, 21.05%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium phosphate and have Pleural effusion?

- Check whether Pleural effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Potassium phosphate:

Potassium phosphate (578 reports)

Pleural effusion treatments and more:

Pleural effusion (84,634 reports)

Browse all side effects of Potassium phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleural effusion:

Pleural effusion (2,224 drugs)

Browse all the conditions that are associated with Pleural effusion:

Pleural effusion (3,144 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium (the active ingredients of Potassium phosphate) and Potassium phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.